Cambrex Opens API Facility in Sweden

Cambrex says it has opened a previously announced $20-million active pharmaceutical ingredients (API) manufacturing facility at Karlskoga, Sweden. The new cGMP facility, which took two year to build, gives Cambrex Karlskoga a flexible production plant, which will increase large-scale production capacity for new APIs. Cambrex Karlskoga produces APIs and during the last ten years, the company has also supported innovative pharmaceutical companies with their drug development...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers